Worldwide Clinical Trials Uses AI with Oncology, Rare Disease Precision

 

In the following article by North Carolina Biotechnology Center, Dr. Elizabeth Witherspoon, NCBiotech Writer, discusses the strategic partnership between Worldwide and Deep Lens to utilize AI technology and develop a greater oncology focus in order to address rapidly changing trial needs.

Courtesy of the North Carolina Biotechnology Center (www.ncbiotech.org) and Author Elizabeth Witherspoon, Ph.D. 

Questions regarding your upcoming clinical trial?